Appetite-suppressing drugs could wipe out millions of fast-food trips. What it means for your choices and your money.

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

Drugs aren’t the foundation of a healthy society. Your editorial raises a valid concern: equitable access to weight-loss drugs like Wegovy. However, while affordability matters, ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a popular platform reveals the hidden risks of online prescriptions.

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

The “Trainwreck” star previously shared she was having a “good experience” with Mounjaro after battling intense nausea on ...

Patients with overweight or obesity and heart failure with preserved ejection fraction that have unintentional weight loss have worse outcomes.

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.